Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates

Nature

Volumn 557, Issue 7706, 2018, Pages 575-579

  Simoni, Yannick ^a   Becht, Etienne ^a   Fehlings, Michael ^a,b   Loh, Chiew Yee ^a   Koo, Si Lin ^c   Teng, Karen Wei Weng ^a   Yeong, Joe Poh Sheng ^a,d   Nahar, Rahul ^e   Zhang, Tong ^e   Kared, Hassen ^a   Duan, Kaibo ^a   Ang, Nicholas ^a   Poidinger, Michael ^a   Lee, Yin Yeng ^e   Larbi, Anis ^a   Khng, Alexis J ^e   Tan, Emile ^d   Fu, Cherylin ^d   Mathew, Ronnie ^d   Teo, Melissa ^c   Lim, Wan Teck ^c   Toh, Chee Keong ^c   Ong, Boon Hean ^f   Koh, Tina ^c   Hillmer, Axel M ^e   Takano, Angela ^d   Lim, Tony Kiat Hon ^d,e,g   Tan, Eng Huat ^c   Zhai, Weiwei ^e   Tan, Daniel S W ^c,e   Tan, Iain Beehuat ^c,e,g   Newell, Evan W ^a   more..

^a AGENCY FOR SCIENCE   (Singapore)

^b ImmunoSCAPE Pte Ltd   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

^f DEPARTMENT OF CARDIOLOGY   (Singapore)

^g DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; APYRASE; ENTPD1 PROTEIN, HUMAN; TUMOR ANTIGEN; VIRUS ANTIGEN;

ANTIGEN; CANCER; CELL; GENE; GENE EXPRESSION; GROWTH; HETEROGENEITY; IMMUNE RESPONSE; PHENOTYPE; TUMOR; VIRUS;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIMIT OF QUANTITATION; LYMPHOCYTE SUBPOPULATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; TUMOR ASSOCIATED LEUKOCYTE; BYSTANDER EFFECT; CELL SEPARATION; COLORECTAL TUMOR; COMPARATIVE STUDY; CYTOLOGY; DEFICIENCY; GENETICS; IMMUNOLOGY; LUNG TUMOR; METABOLISM;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; ORTHOMYXOVIRIDAE;

ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; APYRASE; BYSTANDER EFFECT; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; COLORECTAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 85047608686     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-018-0130-2     Document Type: Article

References (54)

1. Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62-68 (2015).
2. Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69-74 (2015).
3. Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217-221 (2017).
4. Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222-226 (2017).
5. Lavin, Y. et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169, 750-765.e717 (2017).
6. Chevrier, S. et al. An immune atlas of clear cell renal cell carcinoma. Cell 169, 736-749.e718 (2017).
7. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577-581 (2014).
8. + T cells. Nat. Commun. 8, 562 (2017).
9. Liu, X. S. & Mardis, E. R. Applications of immunogenomics to cancer. Cell 168, 600-612 (2017).
10. Yarchoan, M., Johnson, B. A. III, Lutz, E. R., Laheru, D. A. & Jaffee, E. M. Targeting neoantigens to augment antitumour immunity. Nat. Rev. Cancer 17, 209-222 (2017).
11. Zheng, C. et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342-1356.e1316 (2017).
12. Newell, E. W. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol. 31, 623-629 (2013).
13. Khodadoust, M. S. et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature 543, 723-727 (2017).
14. Cohen, C. J. et al. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J. Clin. Invest. 125, 3981-3991 (2015).
15. McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463-1469 (2016).
16. Chheda, Z. S. et al. Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J. Exp. Med. 215, 141-157 (2018).
17. + T-cell responses in hepatocellular carcinoma. Hepatology 59, 1415-1426 (2014).
18. - and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells. Int. J. Cancer 117, 587-595 (2005).
19. Liu, G. et al. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res. 64, 4980-4986 (2004).
20. + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc. Natl Acad. Sci. USA 107, 7875-7880 (2010).
21. Ahmadzadeh, M. et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537-1544 (2009).
22. + T cell effector function. Cancer Cell 26, 923-937 (2014).
23. + tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246-2259 (2014).
24. + T cells infiltrate melanoma lesions and retain function independently of PD-1 expression. J. Immunol. 198, 2979-2988 (2017).
25. + T cells. Cancer Res. 78, 115-128 (2018).
26. + T cells. PLoS Pathog. 11, e1005177 (2015).
27. Soares, A. et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J. Immunol. Methods 362, 43-50 (2010).
28. + T cell exhaustion during chronic viral infection. Immunity 27, 670-684 (2007).
29. + T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350-2360 (2011).
30. Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265-276 (2015).
31. Nahar, R. et al. Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing. Nat. Commun. 9, 216 (2018).
32. Gainor, J. F. et al. EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non-small cell lung cancer: a retrospective analysis. Clin. Cancer Res. 22, 4585-4593 (2018).
33. Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60-65 (2017).
34. Simoni, Y. et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46, 148-161 (2017).
35. Bakker, A. H. et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc. Natl Acad. Sci. USA 105, 3825-3830 (2008).
36. Toebes, M. et al. Design and use of conditional MHC class I ligands. Nat. Med. 12, 246-251 (2006).
37. Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P. & Boon, T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14, 135-146 (2014).
38. Lundegaard, C. et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36, W509-512 (2008).
39. Li, Y. & Ghosh, D. A two-step hierarchical hypothesis set testing framework, with applications to gene expression data on ordered categories. BMC Bioinformatics 15, 108 (2014).
40. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
41. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
42. Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811-1817 (2012).
43. Wang, S. et al. Label-free imaging, detection, and mass measurement of single viruses by surface plasmon resonance. Proc. Natl Acad. Sci. USA 107, 16028-16032 (2010).
44. Liao, Y., Smyth, G. K. & Shi, W. feature Counts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
45. Harrow, J., et al GENCODE: producing a reference annotation for ENCODE. Genome biology 7, 1-9 (2006).
46. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
47. R Core Team. R: A Language and Environment for Statistical Computing https://www.R-project.org/ (R Foundation for Statistical Computing, Vienna, Austria, 2013).
48. + T cell expansions arise during tuberculosis because of TCR selection. PLoS Pathog. 11, e1004849 (2015).
49. Becher, B. et al. High-dimensional analysis of the murine myeloid cell system. Nat. Immunol. 15, 1181-1189 (2014).
50. Wong, M. T. et al. Mapping the diversity of follicular helper T cells in human blood and tonsils using high-dimensional mass cytometry analysis. Cell Reports 11, 1822-1833 (2015).
51. Finck, R. et al. Normalization of mass cytometry data with bead standards. Cytometry A 83, 483-494 (2013).
52. Amir, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545-552 (2013).
53. Van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 85 (2008).
54. Moore, W. A. & Parks, D. R. Update for the logicle data scale including operational code implementations. Cytometry A 81, 273-277 (2012).